| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. | Chief Strategy Officer | Common Stock | 16,660 | 26 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000119312526077716-hoyos-rocio-martin-2026-02-26 | Atrium Therapeutics, Inc. | 26 Feb 2026 | 0 | $0 | 3 | Chief Strategy Officer | 26 Feb 2026, 18:05 |